WORLDCOIN-FOUNDATION
Worldcoin today introduced a protocol update - World ID 2.0, a more powerful, privacy preserving “humanness” digital passport equipped with exciting app integrations* and a suite of new features. Humanness verification services are expanding in Mexico and Singapore, increasing global access to World ID 2.0.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231213314816/en/
The World ID 2.0 Passport. (Photo: Business Wire)
World ID 2.0 makes it easier to distinguish between bots and verified humans online while preserving privacy with popular apps and services with new pre-built integrations. The protocol will be integrated with popular e-commerce, gaming and social media platforms including: Shopify, Mercado Libre, Minecraft, Reddit and Telegram.
Prove personhood, not identity
The rapid global advancement of artificial intelligence has accelerated the need to differentiate between human- and AI-generated content online. As reported by CNBC, retailers are losing an estimated $100 billion per year from return fraud, bots and coupon stacking. Meanwhile, the digital gaming industry struggles to combat bots impacting the real number of humans playing online and have been alleged to fraudulently beat humans in competitive games.
World ID aims to provide a decentralized digital identity layer that enables anonymous actions for the benefit of every unique human online. With the humanness digital passport, individuals can verify to an app or service that they are human without disclosing their identity, and brands can ensure that their offerings and services are being used as intended. World ID 2.0 also offers new verification levels to provide developers choice when implementing humanness verification requirements into their apps or services.
App integrations deliver greater utility
Users and businesses benefit from World ID. New integrations with apps like Shopify, Telegram, Minecraft, Reddit and Mercado Libre, alongside existing integrations with apps including Discord, Talent Protocol and Okta’s Auth0, mean individuals can quickly and easily verify their humanness on the platforms they use every day. And with a new, high-performance developer platform enabling builders to easily integrate “Sign in with World ID” onto their app, new integrations are being added every week, all visible on the new Worldcoin App Store.
New verification levels offer increased access and flexibility
Nearly five million people globally now have a World ID, and more than 2.5 million have verified their humanness at an Orb so they can fully utilize their World ID.
With its new verification levels, World ID 2.0 introduces more ways for people to use their World ID based on the security needs of the application and to ensure individuals are not sharing more information than they need or want for a given application. From device verification for high convenience and accessibility all the way to Orb verification with additional face authentication for high security use cases, there’s now a way for everyone to use their World ID even if they haven’t yet had the opportunity to verify at an Orb.
How to get a World ID
Obtaining a World ID is as simple as downloading a compatible wallet, starting with the World App which is designed to support 94.5% of the iOS and 98.2% of Android smartphones in use today. Initial verification of a World ID offers a baseline level of protection with Device Auth and an Orb-verified World ID provides enhanced utility for applications or services requiring higher security and verification. Visit https://worldcoin.org/find-orb or check the World App to find an Orb verification location near you.
A look at Worldcoin momentum and expansion
Interest in access to Worldcoin and proof of personhood technologies like World ID is continuing to grow globally. In 2023, World ID verifications jumped from under a million in January to more than 2.5 million by the end of November. Additional Orb locations are also opening in both new and existing cities to help make sure everyone who wants to be a part of the Worldcoin community can do so. Mexico and Singapore join the list of locations where individuals can now find Orbs.
About the Worldcoin Foundation
The Worldcoin Foundation, a steward of the Worldcoin protocol until it is self-sufficient, aims to realize more inclusive, fair and just institutions of governance and of the global digital economy.
About the Worldcoin Protocol
The Worldcoin protocol is intended to be the world’s largest, most inclusive identity and financial public utility and to be accessible by everyone. Worldcoin was originally conceived by Sam Altman, Alex Blania and Max Novendstern. The Worldcoin protocol is designed to empower individuals and organizations around the world with the tools they need to participate in the digital economy and advance humanity's progress. Find out more about Worldcoin at www.worldcoin.org, on Twitter/X, Discord, YouTube and Telegram.
*World ID integrations do not imply World ID is an official product, or a partnership, sponsorship, or endorsement, of the companies whose products were integrated, such as Discord, Mercado Libre, Microsoft, Mojang, Reddit, and Shopify.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231213314816/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom